WO2002020442A1 - Verfahren zur hydrierung von c-c-doppelbindungen - Google Patents
Verfahren zur hydrierung von c-c-doppelbindungen Download PDFInfo
- Publication number
- WO2002020442A1 WO2002020442A1 PCT/EP2001/009203 EP0109203W WO0220442A1 WO 2002020442 A1 WO2002020442 A1 WO 2002020442A1 EP 0109203 W EP0109203 W EP 0109203W WO 0220442 A1 WO0220442 A1 WO 0220442A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogenation
- double bond
- range
- ring system
- bond according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Definitions
- the present invention relates to a gentle process for catalytic hydrogenation and a process for the production of biotin using the hydrogenation step.
- European patent EP-B-0 273 270 describes a biotin synthesis in which hydrogenation takes place according to equation I.
- Isopropanol is preferably used as the solvent here.
- Ri is a phenylethyl group
- R 2 is hydrogen, acetyl, propionyl, benzoyl, benzyl, ethoxycarbonyl, tert-butoxycarbonyl, benzyloxycarbonyl, phenoxycarbonyl, p-methoxybenzyl, methoxymethyl, pyranyl, benzeneslfonyl -, p-Toluenesulfonyl-, methylsulfonyl, diphenylphosphinyl, diethoxyphosphinyl, - trimethylsilyl, or a butyldimethylsilyl radical and R 3 is selected from H and C ⁇ . 4 alkyl.
- the European patent application EP-A-0 633 263 describes the hydrogenation with a soluble Pd catalyst, preferably dichlorobis (benzonitrile) palladium or palladium acetate in a solvent mixture of water and at least one alcohol.
- a soluble Pd catalyst preferably dichlorobis (benzonitrile) palladium or palladium acetate in a solvent mixture of water and at least one alcohol.
- the hydrogenation is carried out with palladium acetate in isopropanol.
- the European patent application EP-A-0 780 392 is concerned with the problem of separating such soluble catalysts from the reaction mixture. After the reaction has been carried out, it is proposed to add a polymeric flocculant which precipitates the catalyst out of the solution and filters off the precipitate.
- a first object of the present invention is accordingly a process for the catalytic hydrogenation of at least one C-C double bond in a compound having at least one basic saltable functional group, in which the hydrogenation is carried out in a protic solvent at a pH> 7.
- the double bond is preferably located on a thiazole ring system.
- a thiazole ring system is understood to mean a ring system comprising one or more, preferably fused rings, which contains at least one nitrogen heteroatom and at least one sulfur heteroatom.
- the rings can be saturated or unsaturated.
- the at least one double bond to be hydrogenated can be one or more double bonds in the ring system and / or one or more double bonds directly adjacent to rings in the system.
- the at least one basic saltable functional group is understood to mean such a group which is present in the charged form under the selected hydrogenation conditions.
- the carboxyl or hydroxyl functions are preferred, it being particularly preferred according to the invention if at least one carboxyl function is present.
- the functional group which can be salted under basic conditions is bound to the thiazole ring system either directly or via one or more side chains.
- the process is preferably carried out in such a way that the hydrogenation is enantioselective he follows. It is no problem for the person skilled in the art to select the hydrogenation conditions, in particular catalyst, pressure and temperature, in such a way that enantioselective hydrogenation takes place.
- the thiazole ring system is a thiolane ring system, a thiolane ring system (tetrahydrothiophene derivative) being understood to mean such a ring system which contains at least one substituted or unsubstituted thiolane ring which preferably bound to at least one further ring, preferably fused.
- sulfur-containing cyclopentane ring systems which contain double bonds are also expressly referred to as thiolane ring systems for the purposes of the present invention.
- the thiolane ring system is in a compound of the formula I.
- radicals R1 and R2 represent a protective group
- X represents O or S
- R is selected from the group consisting of the radicals C- ⁇ . 2 contains o-hydroxyalkyl, C1-20 carboxyalkyl and the esters of such hydroxy or carboxyalkyl radicals.
- the protective groups R1 and R2 in formula I are preferably selected from the group consisting of the residues acetyl, propionyl, benzoyl, benzyl, phenylethyl, ethoxycarbonyl, tert-butoxycarbonyl, benzyloxycarbonyl, phenoxycarbonyl, p- Methoxybenzyl, methoxymethyl, pyranyl, benzenesulfonyl, p-toluenesulfonyl, methylsulfonyl, diphenylphosphinyl, diethoxyphosphinyl, trimethylsilyl, trifluoroacetyl, methoxycarbonyl, allyloxycarbonyl, trifluorophenyl and Contains butyldimethylsilyl, where R1 and R2 are preferably identical and are particularly preferably benzyl or phenylethyl.
- Suitable solvents are protic solvents, in particular the customary protic solvents known to those skilled in the art, such as water, lower alcohols, such as, for example, methanol, ethanol and isopropanol, and primary and secondary amines and mixtures of such protic solvents, it being particularly preferred if as the solvent Water is used.
- protic solvents such as water, lower alcohols, such as, for example, methanol, ethanol and isopropanol, and primary and secondary amines and mixtures of such protic solvents, it being particularly preferred if as the solvent Water is used.
- the hydrogenation takes place at a pH> 7 and preferably at a pH ⁇ 10. It is also preferred if the pH in the reaction medium is in the range from 8 to 9, in particular in the range from 8.5 to 8, 9 is set, and it has proven to be particularly advantageous if a pH of about 8.7 is set.
- the pH is preferably adjusted using a weak base, such as sodium carbonate or potassium carbonate, a corresponding buffer system which acts in the weakly alkaline range, or an alkali or alkaline earth metal hydroxide such as sodium hydroxide solution or potassium hydroxide solution.
- a weak base such as sodium carbonate or potassium carbonate
- a corresponding buffer system which acts in the weakly alkaline range
- an alkali or alkaline earth metal hydroxide such as sodium hydroxide solution or potassium hydroxide solution.
- other bases familiar to the person skilled in the art can also be used here.
- All common homogeneous and heterogeneous catalysts are suitable as catalysts for the hydrogenation, in particular. preferably at least one noble metal, preferably selected from the elements Pt, Pd and Rh, or a transition metal, such as Mo, W, Cr, but especially Fe, Co and Ni, is used as the catalyst, either individually or in a mixture.
- the catalyst or catalysts or catalyst mixtures can also be used on supports such as activated carbon, aluminum oxide or kieselguhr.
- the metal can also be used in the form of the Raney compound, for example Raney nickel.
- the catalysis is carried out in a homogeneous process, it is preferred if one or more complex compounds of the metals mentioned, such as, for example, the Wilkinson catalyst [chlorotris (triphenylphosphine) rhodium], is used as the catalyst.
- a heterogeneous catalyst is used, it Pd, preferably on activated carbon carrier, for example 5% by weight Pd on C, is particularly preferably used as catalyst in the process according to the invention.
- the hydrogenation is usually carried out at a temperature in the range of 20-
- the hydrogenation is advantageous in one
- Hydrogen pressure from 1 to 200 bar, preferably from 1 to 10 bar and particularly preferably at about 3 to 5 bar.
- the hydrogenation product is isolated by a pH shift.
- a pH in the range from 1 to 7, preferably around 6, is preferably set.
- the pH shift can preferably be achieved by adding an organic acid or a mineral acid, preferably hydrochloric acid.
- the product in this variant of the invention is preferably extracted with an organic solvent.
- Suitable organic solvents are esters, such as, in particular, ethyl acetate and butyl acetate, ethers, such as, in particular, diethyl ether, MTB ether, methyltetrahydrofuran and tetrahydrofuran, ketones, such as, in particular, ethyl propyl ketone, dichloromethane, chloroform,
- Carbon tetrachloride aliphatic hydrocarbons, such as in particular pentane, hexane and heptane, aromatic hydrocarbons such as benzene, toluene and xylene and its isomer mixtures, with xylene being used with particular preference.
- the method is particularly preferably used as an intermediate step in the production of biotin, in particular of (+) - biotin. It is therefore particularly preferred if the group X in formula I is an oxygen atom and the radical R in formula I is a butyric acid residue, which may be esterified. Accordingly, the present invention furthermore relates to a process for the preparation of biotin, in which the hydrogenation according to the invention is used.
- the thieno [3,4-d] imidazol-4-ylidene pentanoic acid is hydrogenated in the same protic solvent in which the reaction step taking place immediately before the hydrogenation took place.
- the purification of the thieno [3,4-d] imidazol-4-ylidene pentanoic acid with water is carried out as the reaction step preceding the hydrogenation in customary processes for producing biotin. Therefore, water is a particularly preferred solvent in this embodiment of the present invention.
- the thieno [3,4-d] imidazol-4-ylidene-pentanoic acid protected on the nitrogen atoms is preferably first dissolved in water. This is particularly preferably done by alkalizing with a weak base, such as, for example, aqueous sodium hydroxide solution.
- a weak base such as, for example, aqueous sodium hydroxide solution.
- a pH value in the range 8-9, in particular in the range 8.5-8.9, is preferably set, it having proven particularly advantageous if a pH value of 8.7 is set.
- the metal catalyst preferably palladium on a carbon support (for example 5% -Pd / C) is then added.
- a carbon support for example 5% -Pd / C
- the hydrogenation takes place at a temperature in the range from 20 to 150 ° C., preferably in the range from 70 to 120 ° C. and particularly preferably at about 60 ° C. and a hydrogen pressure of from 1 to 200 bar, preferably from 1 to 10 bar and particularly preferably at about 3 to 5 bar.
- the hydrogenation product is preferably isolated by a pH shift, a pH of about 6 preferably being set using hydrochloric acid. After the pH shift has taken place, the product in this variant of the invention is extracted with an organic solvent, preferably xylene.
- aqueous phase is then extracted again with 100 ml of xylene.
- the organic phases are combined and the solvents are evaporated. This leaves 96 g (3aS, 6aR) -hexahydro-2-oxo-1, 3-dibenzylthieno- [3,4-d] -imidazol-4-yl-pentanoic acid (formula II) as a light yellow oil.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002525069A JP2004513085A (ja) | 2000-09-06 | 2001-08-09 | 二重結合の水素化方法 |
EP01976063A EP1339657A1 (de) | 2000-09-06 | 2001-08-09 | Verfahren zur hydrierung von c-c-doppelbindungen |
KR10-2003-7003242A KR20030032009A (ko) | 2000-09-06 | 2001-08-09 | 탄소-탄소 이중 결합의 수소첨가 방법 |
AU2001295453A AU2001295453A1 (en) | 2000-09-06 | 2001-08-09 | Method for hydrogenating c-c double bonds |
US10/363,136 US7094905B2 (en) | 2000-09-06 | 2001-08-09 | Process for the hydrogenation of C—C double bonds |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10043957 | 2000-09-06 | ||
DE10043957.8 | 2000-09-06 | ||
DE10135681A DE10135681A1 (de) | 2000-09-06 | 2001-07-21 | Hydrierverfahren |
DE10135681.1 | 2001-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002020442A1 true WO2002020442A1 (de) | 2002-03-14 |
Family
ID=26006944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/009203 WO2002020442A1 (de) | 2000-09-06 | 2001-08-09 | Verfahren zur hydrierung von c-c-doppelbindungen |
Country Status (6)
Country | Link |
---|---|
US (1) | US7094905B2 (de) |
EP (1) | EP1339657A1 (de) |
JP (1) | JP2004513085A (de) |
CN (1) | CN100369872C (de) |
AU (1) | AU2001295453A1 (de) |
WO (1) | WO2002020442A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106892931B (zh) * | 2016-12-28 | 2019-01-11 | 安徽泰格生物技术股份有限公司 | 一种生物素中间体的提纯方法 |
CN112403504B (zh) * | 2020-12-07 | 2022-04-19 | 厦门大学 | 一种氮硫共掺杂催化剂及其制备方法和应用 |
WO2023120711A1 (ja) * | 2021-12-24 | 2023-06-29 | 株式会社トクヤマ | ビオチン誘導体の製造方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4792625A (en) * | 1986-07-31 | 1988-12-20 | Yissum Research Development Company | Process for the reduction of organic compounds using alkali formate salts |
EP0570824A2 (de) * | 1992-05-18 | 1993-11-24 | The Goodyear Tire & Rubber Company | Verfahren zur selektiven Reduktion von ungesättigten organischen Verbindungen |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2125820C (en) * | 1993-07-08 | 2006-05-02 | Masahiko Mizuno | Process for producing thiophene derivative |
-
2001
- 2001-08-09 WO PCT/EP2001/009203 patent/WO2002020442A1/de active Application Filing
- 2001-08-09 CN CNB018151752A patent/CN100369872C/zh not_active Expired - Fee Related
- 2001-08-09 JP JP2002525069A patent/JP2004513085A/ja active Pending
- 2001-08-09 EP EP01976063A patent/EP1339657A1/de not_active Withdrawn
- 2001-08-09 AU AU2001295453A patent/AU2001295453A1/en not_active Abandoned
- 2001-08-09 US US10/363,136 patent/US7094905B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4792625A (en) * | 1986-07-31 | 1988-12-20 | Yissum Research Development Company | Process for the reduction of organic compounds using alkali formate salts |
EP0570824A2 (de) * | 1992-05-18 | 1993-11-24 | The Goodyear Tire & Rubber Company | Verfahren zur selektiven Reduktion von ungesättigten organischen Verbindungen |
Non-Patent Citations (4)
Title |
---|
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002186069, Database accession no. 852627 (reaction ID) * |
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002186070, Database accession no. 8678322 (reaction ID) * |
M. A. NAZARENO ET AL., MOLECULES, vol. 5, no. 3, 2000, pages 589 - 590 * |
R. J. BONILLA ET AL., CHEM. COMMUN., no. 11, 2000, pages 941 - 942 * |
Also Published As
Publication number | Publication date |
---|---|
EP1339657A1 (de) | 2003-09-03 |
CN100369872C (zh) | 2008-02-20 |
US20040030150A1 (en) | 2004-02-12 |
JP2004513085A (ja) | 2004-04-30 |
CN1452604A (zh) | 2003-10-29 |
AU2001295453A1 (en) | 2002-03-22 |
US7094905B2 (en) | 2006-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005000187T2 (de) | Verfahren zur Herstellung von (1S)-4,5-Dimethoxy-1-(methylaminomethyl)-benzocyclobutan und deren Säureadditionssalze, sowie ihre Verwendung für die Synthese von Ivabradin und deren Säureadditionssalze von pharmazeutischen verträglichen Säure | |
DD264920A5 (de) | Verfahren zur herstellung von (+)-biotin | |
AT390253B (de) | Verfahren zur herstellung der d-2-(6-methoxy-2naphthyl)-propionsaeure | |
WO2002020442A1 (de) | Verfahren zur hydrierung von c-c-doppelbindungen | |
DE60103179T2 (de) | Synthese von r-(+)-alpha-liponsäure | |
DE3309159A1 (de) | Neue optisch aktive chromanderivate, verfahren zu deren herstellung sowie neue zwischenprodukte | |
EP0107806B1 (de) | Verfahren zur Herstellung von optisch aktiven Hydrochinonderivaten sowie von d-alpha-Tocopherol | |
DE60313157T2 (de) | Ein verfahren zur herstellung von clopidogrel | |
DE10135681A1 (de) | Hydrierverfahren | |
DE19962661B4 (de) | Verfahren zur Herstellung von Hexahydro-2-oxo-1H-thieno[3,4-d]-imidazol-4-pentansäure | |
CN1315953A (zh) | 制备咪唑并二氮杂环庚三烯中间体的方法 | |
DE3341883A1 (de) | Verfahren zur herstellung von reinen 3-acetylaminoanilinen | |
DE69910983T2 (de) | Synthese von chiralen beta-aminosäuren | |
DE602005003672T2 (de) | VERBESSERTES VERFAHREN ZUR HERSTELLUNG VON 5,6 -DIHYDRO -4H-4(S)-ETHYLAMIN-6(S)-METHYLTHIENOÄ2,3-bÜ THIOPYRAN-2-SULFONAMID- 7,7 -DIOXID UND SEINEN SALZEN | |
DE2558508C3 (de) | Verfahren zur Racematspaltung von DL-Pantolacton | |
DE19610323C2 (de) | Verfahren zur Herstellung von N-Lauroyl-L-glutaminsäure-di-n-butylamid | |
AT395148B (de) | Verfahren zur herstellung von 1-(3-mercapto-(2s)methyl-1-oxo-propyl)-l-prolin | |
WO1998041504A1 (de) | Verfahren zur herstellung von 5-aminomethyl-2-chlorpyridinen | |
CH665638A5 (de) | Verfahren zur herstellung von 2,3-dihydro-7-aminobenzofuranen. | |
CH618445A5 (de) | ||
EP0110202B1 (de) | Verfahren zur Herstellung von Phenylethanolaminen | |
DE2931295C2 (de) | ||
DE60203008T2 (de) | Verbesserte synthesen von allofuranose | |
WO1998017613A1 (de) | Verfahren zur herstellung von 2-methyl-4-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-but-2-en-1-ol | |
WO2005019154A1 (de) | VERFAHREN ZUR HERSTELLUNG VON α-FLUOR-MALONSÄUREDIALKYLESTERN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001976063 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037003242 Country of ref document: KR Ref document number: 018151752 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10363136 Country of ref document: US Ref document number: 2002525069 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037003242 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001976063 Country of ref document: EP |